Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-07-03-Speech-2-446-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-07-03"^^xsd:date2
dcterms:Is Part Of	lp_eu:Anti-Counterfeiting Trade Agreement between the EU and its Member States, Australia, Canada, Japan, the Republic of Korea, Mexico, Morocco, New Zealand, Singapore, Switzerland and the USA (debate)2
dcterms:Language	"nl"^^xsd:language2
lpv:document identification number	"en.20120703.21.2-446-000"2
lpv:hasSubsequent	lp_eu:2012-07-03-Speech-2-447-0002
lpv:speaker	lp:Judith Sargentini2
lpv:spokenAs	substitute; Delegation to the EU-Turkey Joint Parliamentary Committee (2010-03-03--2014-06-30)3 vice-chair; Delegation for relations with South Africa (2009-09-30--2014-06-30)3 member; LIBE (2012-01-19--2014-06-30)3 member; G/EFA (2009-07-14--2014-06-30)3 substitute; DEVE (2012-01-19--2014-06-30)3 unknown; GroenLinks (2009-07-14--2014-06-30)3
lpv:translated text	"I heard Ms Gallo say that the purpose of ACTA is to protect the health of European citizens. My question to Ms Gallo is: are you aware that medicines that are properly counterfeited can save lives? That properly counterfeited medicines are affordable for people in developing countries and that, through them, they can receive the kind of health care which they would not have if we were to enforce copyright, the intellectual property right, on medicines in the manner suggested by ACTA?"@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph